Table 1 Demographics and healing outcomes in the three study groups.
Patient level | Total (n = 105) | Group CB (n = 29) | Group RW (n = 28) | Group UT (n = 48) |
|---|---|---|---|---|
Age (years) | 62.1 ± 11.1 | 57.5 ± 10.6 | 64.1 ± 11.6 | 63.8 ± 10.5 |
Sex (male: female) | 62:43 | 18:11 | 14:14 | 30:18 |
Follow-up period (years) | 4.3 ± 1.4 | 4.8 ± 1.4 | 3.6 ± 1.2 | 4.4 ± 1.3 |
CV | 37 | 10 | 8 | 19 |
DM | 10 | 4 | 1 | 5 |
Smoking | 28 | 10 | 6 | 12 |
Implant failure | 1 | 0 | 1 | 0 |
Implant level | Total (n = 266) | Group CB (n = 72) | Group RW (n = 64) | Group UT (n = 130) |
|---|---|---|---|---|
Implant length | 10.2 ± 0.6 mm | 10.2 ± 0.7 mm | 10.1 ± 0.4 mm | 10.2 ± 0.6 mm |
Implant diameter | 4.5 ± 0.4 mm | 4.6 ± 0.5 mm | 4.5 ± 0.4 mm | 4.5 ± 0.4 mm |
Bone height at T0 | 2.7 ± 0.9 mm | 2.3 ± 0.8 mm | 3.2 ± 0.8 mm | 2.8 ± 0.8 mm |
Bone height at T1 | 17.4 ± 2.7 mm | 17.2 ± 2.6 mm | 17.8 ± 2.7 mm | 17.3 ± 2.8 mm |
Bone height at T2 | 16.4 ± 2.8 mm | 16.2 ± 2.7 mm | 17.0 ± 2.7 mm | 16.3 ± 3.0 mm |
Bone height at T3 | 16.0 ± 2.9 mm | 15.8 ± 2.7 mm | 16.4 ± 2.9 mm | 15.9 ± 3.0 mm |
Marginal bone level change (mesial) | 0.1 ± 0.4 mm | 0.2 ± 0.7 mm | 0.0 ± 0.0 mm | 0.1 ± 0.3 mm |
Marginal bone level change (distal) | 0.2 ± 0.6 mm | 0.3 ± 0.9 mm | 0.1 ± 0.2 mm | 0.1 ± 0.4 mm |
Marginal bone level change | 0.1 ± 0.5 mm | 0.3 ± 0.8 mm | 0.0 ± 0.1 mm | 0.1 ± 0.3 mm |
Implant failure | 2 | 0 | 2 | 0 |
